Evidence map›Paper›PMID 26625131›Full record

ArticleJournal of women's health (2002)2016

Impact of Patient Navigation Interventions on Timely Diagnostic Follow Up for Abnormal Cervical Screening.

Electra D Paskett, Donald Dudley, Gregory S Young, Brittany M Bernardo, Kristen J Wells, Elizabeth A Calhoun, Kevin Fiscella, Steven R Patierno, Victoria Warren-Mears, Tracy A Battaglia and 1 more

Abstract read
In one paragraph

Article in Journal of women's health (2002), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Electra D Paskett1 Division of Cancer Prevention and Control, Ohio State University , Columbus, Ohio.
Donald Dudley3 Department of Obstetrics and Gynecology, University of Texas Health Science Center at San Antonio , San Antonio, Texas.
Gregory S Young4 Center for Biostatistics, Ohio State University , Columbus, Ohio.
Brittany M Bernardo2 Comprehensive Cancer Center, Ohio State University , Columbus, Ohio.
Kristen J Wells5 Department of Psychology, San Diego State University , San Diego, California.
Elizabeth A Calhoun6 Division of Health Policy and Administration, School of Public Health, University of Illinois at Chicago , Chicago, Illinois.
Kevin Fiscella7 Division of Oncology, Department of Family Medicine, Community, and Preventive Medicine, James P. Wilmont Cancer Center, University of Rochester , Rochester, New York.
Steven R Patierno8 George Washington University Cancer Institute , Washington, DC.
Victoria Warren-Mears10 Northwest Portland Area Indian Health Board, Northwest Tribal Epidemiology Center , Portland, Oregon.
Tracy A Battaglia11 Women's Health Unit, Section of General Internal Medicine, Evans Department of Medicine, Boston Medical Center and Women's Health Interdisciplinary Research Center, Boston University School of Medicine , Boston, Massachusetts.
PNRP Investigators
The Ohio State University · USGeorge Washington University · USNorthwest Portland Area Indian Health Board · USSan Diego State University · USThe University of Texas Health Science Center at San Antonio · USUniversity of Illinois Chicago · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Chicago Cancer Navigation ProjectU01CA116875 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROSEN, STEVEN TERRY · 2005 to 2011
$4.5M
RCT of Primary Care-based Patient Navigation-ActivationU01CA116924 · NCI · UNIVERSITY OF ROCHESTER · PI FISCELLA, KEVIN ANTHONY · 2005 to 2011
$4.4M
"Patient Navigation in the SafetyNet: CONNECTeDD"U01CA116892 · NCI · BOSTON MEDICAL CENTER · PI FREUND, KAREN · 2005 to 2010
$4.3M
DC City-wide Patient Navigation Research ProgramU01CA116937 · NCI · GEORGE WASHINGTON UNIVERSITY · PI PATIERNO, STEVEN R · 2005 to 2011
$4.1M
Behavioral Oncology Education & Career DevelopmentR25CA090314 · NCI · H. LEE MOFFITT CANCER CTR &RES INST · PI BRANDON, THOMAS H · 2003 to 2018
$4.0M
Improving Patient Outcomes Through System NavigationU01CA116903 · NCI · DENVER HEALTH AND HOSPITAL AUTHORITY · PI RAICH, PETER CHRISTIAN · 2005 to 2011
$3.8M
Patient Navigation Research ProgramU01CA116885 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI DUDLEY, DONALD J · 2005 to 2010
$3.3M
Patient Navigator ProgramU01CA117281 · NCI · H. LEE MOFFITT CANCER CTR &RES INST · PI ROETZHEIM, RICHARD G · 2005 to 2009
$3.1M
Northwest Tribal Cancer Navigator ProgramU01CA116925 · NCI · NORTHWEST PORTLAND AREA INDIAN HLTH BD · PI WARREN-MEARS, VICTORIA ANN · 2005 to 2009
$3.0M
NCI NIH HHS 01CA116937NCI NIH HHS P30 CA016058NCI NIH HHS R25 CA090314NCI NIH HHS U01CA116875NCI NIH HHS U01CA116885NCI NIH HHS U01 CA116892NCI NIH HHS U01CA116903NCI NIH HHS U01CA116924NCI NIH HHS U01CA116925NCI NIH HHS U01 CA117281
6 · The paper itself

Abstract

objectiveAs part of the Patient Navigation Research Program, we examined the effect of patient navigation versus usual care on timely diagnostic follow-up, defined as clinical management for women with cervical abnormalities within accepted time frames.

methodsParticipants from four Patient Navigation Research Program centers were divided into low- and high-risk abnormality groups and analyzed separately. Low-risk participants (n = 2088) were those who enrolled with an initial Pap test finding of atypical squamous cells of undetermined significance (ASCUS) with a positive high-risk human papillomavirus (HPV) serotype, atypical glandular cells, or low-grade squamous intraepithelial lesion (LGSIL). High-risk participants were those with an initial finding of high-grade squamous intraepithelial lesion (HGSIL) (n = 229). A dichotomous outcome of timely diagnostic follow-up within 180 days was used for the low-risk abnormality group and timely diagnostic follow-up within 60 days for the high-risk group, consistent with treatment guidelines. A logistic mixed-effects regression model was used to evaluate the intervention effect using a random effect for study arm within an institution. A backward selection process was used for multivariable model building, considering the impact of each predictor on the intervention effect.

resultsLow-risk women in the patient navigation arm showed an improvement in the odds of timely diagnostic follow-up across all racial groups, but statistically significant effects were only observed in non-English-speaking Hispanics (OR 5.88, 95% CI 2.81-12.29). No effect was observed among high-risk women.

conclusionThese results suggest that patient navigation can improve timely diagnostic follow-up among women with low-risk cervical abnormalities, particularly in non-English-speaking Hispanic women.

Indexed as

Continuity of Patient CarePapanicolaou TestPatient NavigationVaginal SmearsAdultFemaleFollow-Up StudiesHumansMultivariate AnalysisPapillomavirus InfectionsPregnancyRisk FactorsTime FactorsUnited StatesUterine Cervical DysplasiaUterine Cervical Neoplasms

Identifiers

PMID26625131
PMCPMC4741208
OpenAlexW2183984955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.